• Michael K Keng, Elaine A Thallner, Paul Elson, Christine Ajon, Jennifer Sekeres, Candice M Wenzell, David J Seastone, Erika M Gallagher, Catherine M Weber, Marc A Earl, Sudipto Mukherjee, Brad Pohlman, Eric Cober, Virginia B Foster, Joy Yuhas, Matt E Kalaycio, Brian J Bolwell, and Mikkael A Sekeres.
• Cleveland Clinic, Cleveland, OH.
• J Oncol Pract. 2015 Nov 1; 11 (6): 450-5.

PurposeFebrile neutropenia (FN) is an oncologic emergency, and prolonged time to antibiotic administration (TTA) is associated with increased hospital length of stay (LOS) and worse outcomes. We hypothesized that a febrile neutropenia pathway (FNP) quality initiative project would reduce TTA delays for febrile patients with cancer presenting to the emergency department (ED).MethodsThis prospective study compared ED FNP patients (> 18 years old), between June 2012 and June 2013 with both historical and direct admissions (DA) cohorts at a multispecialty academic center. Interventions included providing patients with FN-Alert cards, standardizing the definition of FN and recognizing it as a distinct chief complaint, revising ED triage level for FN, creating electronic FN order sets, administering empiric antibiotics before neutrophil count result, and relocating FN antibiotics to the ED. The primary outcome was TTA, with a target goal of 90 minutes after ED presentation.ResultsIn total, 276 FN episodes in 223 FNP patients occurred over the 12-month study period and were compared with 107 episodes in 87 patients and 114 episodes in 101 patients in the historical and DA cohorts, respectively. Use of the FNP reduced TTA from 235 and 169 minutes in historical and DA cohorts, respectively, to 81 minutes, and from 96 to 68 minutes when the order set was not used versus used in the FNP group (P < .001 for all comparisons). Decrease in hospital LOS was not statistically significant.ConclusionThe ED FNP is a significant quality initiative with sustainable interventions, and was able to demonstrate value by decreasing TTA compared to both historical and DA controls in cancer patients presenting to the ED.Copyright © 2015 by American Society of Clinical Oncology.

23 keywords...

hide…